SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2ipp'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1AQ7_B_AG2B4_1
(TRYPSIN
AERUGINOSIN 98-B)		 2ipp CATHEPSIN B
(Homo
sapiens) 		5 / 8 SER B  90
SER A  39
VAL B  52
GLY B  92
GLY B  99
 None
 1.23A 1aq7A-2ippB:
undetectable		 1aq7A-2ippB:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1STF_E_CCSE25_0
(PAPAIN
STEFIN B (CYSTATIN
B))		 2ipp CATHEPSIN B
CATHEPSIN B
(Homo
sapiens;
Homo
sapiens) 		7 / 10 GLN A  23
GLY A  27
SER A  28
TRP A  30
PHE A  32
HIS B 199
ALA B 200
 PYS  A 255 ( 4.7A)
PYS  A 255 (-3.3A)
None
None
None
None
None
 0.35A 1stfE-2ippA:
undetectable
1stfI-2ippA:
undetectable		 1stfE-2ippA:
10.19
1stfI-2ippA:
15.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TNL_A_TPAA900_1
(TRYPSIN)		 2ipp CATHEPSIN B
(Homo
sapiens) 		4 / 6 SER A  39
VAL B  52
GLY B  92
GLY B  99
 None
 0.77A 1tnlA-2ippA:
undetectable		 1tnlA-2ippA:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_B_STIB600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2ipp CATHEPSIN B
(Homo
sapiens) 		4 / 6 LEU B 181
VAL B 246
ILE B 201
MET B 195
 None
 1.19A 2hyyB-2ippB:
undetectable		 2hyyB-2ippB:
20.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_C_STIC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2ipp CATHEPSIN B
(Homo
sapiens) 		4 / 6 LEU B 181
VAL B 246
ILE B 201
MET B 195
 None
 1.15A 2hyyC-2ippB:
undetectable		 2hyyC-2ippB:
20.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OIQ_A_STIA1001_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 2ipp CATHEPSIN B
(Homo
sapiens) 		4 / 5 LEU B 181
VAL B 246
MET B 195
ARG B 235
 None
 1.06A 2oiqA-2ippB:
undetectable		 2oiqA-2ippB:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2OTV_A_NCAA1301_0
(CATIONIC TRYPSIN)		 2ipp CATHEPSIN B
CATHEPSIN B
(Homo
sapiens;
Homo
sapiens) 		5 / 6 ASP B 143
SER A  39
VAL B  52
GLY B  91
GLY B  99
 None
 1.39A 2otvA-2ippB:
undetectable		 2otvA-2ippB:
21.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3AI8_A_HNQA255_1
(CATHEPSIN B)		 2ipp CATHEPSIN B
(Homo
sapiens) 		6 / 7 GLN A  23
GLY A  27
HIS B 110
HIS B 111
HIS B 199
TRP B 221
 PYS  A 255 ( 4.7A)
PYS  A 255 (-3.3A)
None
None
None
None
 0.45A 3ai8A-2ippA:
undetectable		 3ai8A-2ippA:
95.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3AI8_B_HNQB255_1
(CATHEPSIN B)		 2ipp CATHEPSIN B
(Homo
sapiens) 		5 / 6 GLN A  23
GLY A  27
HIS B 110
HIS B 111
TRP B 221
 PYS  A 255 ( 4.7A)
PYS  A 255 (-3.3A)
None
None
None
 0.34A 3ai8B-2ippA:
undetectable		 3ai8B-2ippA:
95.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2ipp CATHEPSIN B
(Homo
sapiens) 		4 / 7 LEU B 181
VAL B 246
ILE B 201
MET B 195
 None
 1.33A 3ik3A-2ippB:
undetectable		 3ik3A-2ippB:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2ipp CATHEPSIN B
(Homo
sapiens) 		4 / 7 LEU B 181
VAL B 246
MET B 195
ARG B 235
 None
 1.15A 3ik3A-2ippB:
undetectable		 3ik3A-2ippB:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_B_0LIB2_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2ipp CATHEPSIN B
(Homo
sapiens) 		4 / 7 LEU B 181
VAL B 246
MET B 195
ARG B 235
 None
 1.17A 3ik3B-2ippB:
undetectable		 3ik3B-2ippB:
21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K5V_A_STIA2_2
(TYROSINE-PROTEIN
KINASE ABL1)		 2ipp CATHEPSIN B
(Homo
sapiens) 		4 / 6 LEU B 181
VAL B 246
ILE B 201
MET B 195
 None
 1.22A 3k5vA-2ippB:
undetectable		 3k5vA-2ippB:
20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TJ7_A_ACTA604_0
(GBAA_1210 PROTEIN)		 2ipp CATHEPSIN B
(Homo
sapiens) 		5 / 6 TYR B 136
GLY B  99
VAL B  52
HIS B 145
SER B  90
 None
 1.48A 3tj7A-2ippB:
undetectable
3tj7B-2ippB:
undetectable		 3tj7A-2ippB:
19.38
3tj7B-2ippB:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TJ7_C_ACTC606_0
(GBAA_1210 PROTEIN)		 2ipp CATHEPSIN B
(Homo
sapiens) 		5 / 6 TYR B 136
GLY B  99
VAL B  52
HIS B 145
SER B  90
 None
 1.50A 3tj7C-2ippB:
undetectable
3tj7D-2ippB:
undetectable		 3tj7C-2ippB:
19.38
3tj7D-2ippB:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YMG_B_SAMB1001_1
(PUTATIVE
SAM-DEPENDENT
O-METHYLTRANFERASE)		 2ipp CATHEPSIN B
(Homo
sapiens) 		3 / 3 SER B 220
GLU B  53
GLU B 133
 None
 0.79A 4ymgB-2ippB:
undetectable		 4ymgB-2ippB:
22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6IFT_A_SAMA301_0
(RIBOSOMAL RNA SMALL
SUBUNIT
METHYLTRANSFERASE A)		 2ipp CATHEPSIN B
(Homo
sapiens) 		5 / 12 GLU B 171
ILE B 201
GLY B 172
ALA B  77
VAL B 217
 None
 0.98A 6iftA-2ippB:
undetectable		 6iftA-2ippB:
19.52